{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:14:21Z","timestamp":1788614061312,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009843","name":"South Australian Health and Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00018-020-03491-1","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T12:02:51Z","timestamp":1584100971000},"page":"249-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-8016","authenticated-orcid":false,"given":"Jianling","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7949-5533","authenticated-orcid":false,"given":"Kaikai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-4631","authenticated-orcid":false,"given":"Andrew R.","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-7231","authenticated-orcid":false,"given":"Ming Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4644-7022","authenticated-orcid":false,"given":"James E.","family":"Merrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-1030","authenticated-orcid":false,"given":"Roman V.","family":"Lenchine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3734-4670","authenticated-orcid":false,"given":"Stuart","family":"De Poi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-1734","authenticated-orcid":false,"given":"Kirk B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-3433","authenticated-orcid":false,"given":"Paul J.","family":"Trim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-7274","authenticated-orcid":false,"given":"Marten F.","family":"Snel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-0783","authenticated-orcid":false,"given":"Makoto","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-3478","authenticated-orcid":false,"given":"Sally Kim","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-6807","authenticated-orcid":false,"given":"Stephen","family":"Fitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2698-3220","authenticated-orcid":false,"given":"Lisa M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-6167","authenticated-orcid":false,"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Proud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"3491_CR1","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.1005320107","volume":"107","author":"L Furic","year":"2010","unstructured":"Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A, Petroulakis E, Robichaud N, Pollak M, Gaboury LA et al (2010) eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci USA 107:14134\u201314139","journal-title":"Proc Natl Acad Sci USA"},{"key":"3491_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.gde.2017.10.011","volume":"48","author":"S Biffo","year":"2017","unstructured":"Biffo S, Manfrini N, Ricciardi S (2017) Crosstalks between translation and metabolism in cancer. Curr Opin Genet Dev 48:75\u201381","journal-title":"Curr Opin Genet Dev"},{"key":"3491_CR3","doi-asserted-by":"crossref","first-page":"21684","DOI":"10.1074\/jbc.270.37.21684","volume":"270","author":"A Flynn","year":"1995","unstructured":"Flynn A, Proud CG (1995) Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells. J Biol Chem 270:21684\u201321688","journal-title":"J Biol Chem"},{"key":"3491_CR4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/emboj\/16.8.1909","volume":"16","author":"AJ Waskiewicz","year":"1997","unstructured":"Waskiewicz AJ, Flynn A, Proud CG, Cooper JA (1997) Mitogen-activated protein kinases activate the serine\/threonine kinases Mnk1 and Mnk2. EMBO J 16:1909\u20131920","journal-title":"EMBO J"},{"key":"3491_CR5","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","volume":"24","author":"T Ueda","year":"2004","unstructured":"Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R (2004) Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24:6539\u20136549","journal-title":"Mol Cell Biol"},{"key":"3491_CR6","first-page":"20","volume":"20","author":"CG Proud","year":"2018","unstructured":"Proud CG (2018) Phosphorylation and signal transduction pathways in translational control. Cold Spring Harb Perspect Biol 20:20","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3491_CR7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbagrm.2014.10.003","volume":"1849","author":"CG Proud","year":"2015","unstructured":"Proud CG (2015) Mnks, eIF4E phosphorylation and cancer. Biochim Biophys Acta 1849:766\u2013773","journal-title":"Biochim Biophys Acta"},{"key":"3491_CR8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tibs.2016.07.008","volume":"41","author":"CR Bramham","year":"2016","unstructured":"Bramham CR, Jensen KB, Proud CG (2016) Tuning specific translation in cancer metastasis and synaptic memory: control at the MNK-eIF4E axis. Trends Biochem Sci 41:847\u2013858","journal-title":"Trends Biochem Sci"},{"key":"3491_CR9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/emboj\/18.1.270","volume":"18","author":"S Pyronnet","year":"1999","unstructured":"Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T, Sonenberg N (1999) Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J 18:270\u2013279","journal-title":"EMBO J"},{"key":"3491_CR10","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.2741\/3086","volume":"13","author":"M Buxade","year":"2008","unstructured":"Buxade M, Parra-Palau JL, Proud CG (2008) The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front Biosci 13:5359\u20135373","journal-title":"Front Biosci"},{"key":"3491_CR11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","volume":"13","author":"AA Samatar","year":"2014","unstructured":"Samatar AA, Poulikakos PI (2014) Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov 13:928\u2013942","journal-title":"Nat Rev Drug Discov"},{"key":"3491_CR12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/MCB.21.3.743-754.2001","volume":"21","author":"GC Scheper","year":"2001","unstructured":"Scheper GC, Morrice NA, Kleijn M, Proud CG (2001) The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells. Mol Cell Biol 21:743\u2013754","journal-title":"Mol Cell Biol"},{"key":"3491_CR13","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1128\/MCB.23.16.5692-5705.2003","volume":"23","author":"GC Scheper","year":"2003","unstructured":"Scheper GC, Parra JL, Wilson M, Van Kollenburg B, Vertegaal AC, Han ZG, Proud CG (2003) The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization. Mol Cell Biol 23:5692\u20135705","journal-title":"Mol Cell Biol"},{"key":"3491_CR14","doi-asserted-by":"crossref","first-page":"44197","DOI":"10.1074\/jbc.M302398200","volume":"278","author":"JL Parra-Palau","year":"2003","unstructured":"Parra-Palau JL, Scheper GC, Wilson ML, Proud CG (2003) Features in the N and C termini of the MAPK-interacting kinase Mnk1 mediate its nucleocytoplasmic shuttling. J Biol Chem 278:44197\u201344204","journal-title":"J Biol Chem"},{"key":"3491_CR15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/emboj\/16.8.1921","volume":"16","author":"R Fukunaga","year":"1997","unstructured":"Fukunaga R, Hunter T (1997) MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16:1921\u20131933","journal-title":"EMBO J"},{"key":"3491_CR16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1146\/annurev.biochem.68.1.913","volume":"68","author":"AC Gingras","year":"1999","unstructured":"Gingras AC, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913\u2013963","journal-title":"Annu Rev Biochem"},{"key":"3491_CR17","first-page":"e28174","volume":"2","author":"J Xie","year":"2014","unstructured":"Xie J, Proud CG (2014) Signaling crosstalk between the mTOR complexes. Translation (Austin) 2:e28174","journal-title":"Translation (Austin)"},{"key":"3491_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 169:361\u2013371","journal-title":"Cell"},{"key":"3491_CR19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","volume":"13","author":"DA Fruman","year":"2014","unstructured":"Fruman DA, Rommel C (2014) PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13:140\u2013156","journal-title":"Nat Rev Drug Discov"},{"key":"3491_CR20","first-page":"F1000","volume":"5","author":"J Xie","year":"2016","unstructured":"Xie J, Wang X, Proud CG (2016) mTOR inhibitors in cancer therapy. F1000Res 5:F1000","journal-title":"F1000Res"},{"key":"3491_CR21","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.febslet.2013.06.045","volume":"587","author":"RL Stead","year":"2013","unstructured":"Stead RL, Proud CG (2013) Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a). FEBS Lett 587:2623\u20132628","journal-title":"FEBS Lett"},{"key":"3491_CR22","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1038\/onc.2017.233","volume":"36","author":"LS D'Abronzo","year":"2017","unstructured":"D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP et al (2017) The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene 36:6359\u20136373","journal-title":"Oncogene"},{"key":"3491_CR23","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.18632\/oncotarget.2319","volume":"5","author":"F Eckerdt","year":"2014","unstructured":"Eckerdt F, Beauchamp E, Bell J, Iqbal A, Su B, Fukunaga R, Lulla RR, Goldman S, Platanias LC (2014) Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells. Oncotarget 5:8442\u20138451","journal-title":"Oncotarget"},{"key":"3491_CR24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1172\/JCI70198","volume":"124","author":"M Grzmil","year":"2014","unstructured":"Grzmil M, Huber RM, Hess D, Frank S, Hynx D, Moncayo G, Klein D, Merlo A, Hemmings BA (2014) MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. J Clin Invest 124:742\u2013754","journal-title":"J Clin Invest"},{"key":"3491_CR25","doi-asserted-by":"crossref","first-page":"e24849","DOI":"10.1371\/journal.pone.0024849","volume":"6","author":"M Marzec","year":"2011","unstructured":"Marzec M, Liu X, Wysocka M, Rook AH, Odum N, Wasik MA (2011) Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells. PLoS ONE 6:e24849","journal-title":"PLoS ONE"},{"key":"3491_CR26","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/MCB.00760-07","volume":"27","author":"X Wang","year":"2007","unstructured":"Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Fu H, Khuri FR, Sun SY (2007) Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation. Mol Cell Biol 27:7405\u20137413","journal-title":"Mol Cell Biol"},{"key":"3491_CR27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","volume":"70","author":"CM Chresta","year":"2010","unstructured":"Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE, Vincent JP, Ellston R, Jones D, Sini P et al (2010) AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 70:288\u2013298","journal-title":"Cancer Res"},{"key":"3491_CR28","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.1074\/jbc.275.15.11249","volume":"275","author":"TP Herbert","year":"2000","unstructured":"Herbert TP, Kilhams GR, Batty IH, Proud CG (2000) Distinct signalling pathways mediate insulin and phorbol ester-stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells. J Biol Chem 275:11249\u201311256","journal-title":"J Biol Chem"},{"key":"3491_CR29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.celrep.2017.01.023","volume":"18","author":"MC Brown","year":"2017","unstructured":"Brown MC, Gromeier M (2017) MNK controls mTORC1: substrate association through regulation of TELO2 binding with mTORC1. Cell Rep 18:1444\u20131457","journal-title":"Cell Rep"},{"key":"3491_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","volume":"110","author":"K Hara","year":"2002","unstructured":"Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110:177\u2013189","journal-title":"Cell"},{"key":"3491_CR31","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.1074\/jbc.M800723200","volume":"283","author":"L Wang","year":"2008","unstructured":"Wang L, Harris TE, Lawrence JC Jr (2008) Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J Biol Chem 283:15619\u201315627","journal-title":"J Biol Chem"},{"key":"3491_CR32","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","volume":"20","author":"X Wang","year":"2001","unstructured":"Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG (2001) Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 20:4370\u20134379","journal-title":"EMBO J"},{"key":"3491_CR33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20111536","volume":"442","author":"CR Pigott","year":"2012","unstructured":"Pigott CR, Mikolajek H, Moore CE, Finn SJ, Phippen CW, Werner JM, Proud CG (2012) Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains. Biochem J 442:105\u2013118","journal-title":"Biochem J"},{"key":"3491_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163\u2013175","journal-title":"Cell"},{"key":"3491_CR35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0960-9822(02)00762-5","volume":"12","author":"SS Schalm","year":"2002","unstructured":"Schalm SS, Blenis J (2002) Identification of a conserved motif required for mTOR signaling. Curr Biol 12:632\u2013639","journal-title":"Curr Biol"},{"key":"3491_CR36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0960-9822(03)00329-4","volume":"13","author":"SS Schalm","year":"2003","unstructured":"Schalm SS, Fingar DC, Sabatini DM, Blenis J (2003) TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol 13:797\u2013806","journal-title":"Curr Biol"},{"key":"3491_CR37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm101520v","volume":"54","author":"Q Liu","year":"2011","unstructured":"Liu Q, Wang J, Kang SA, Thoreen CC, Hur W, Ahmed T, Sabatini DM, Gray NS (2011) Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer. J Med Chem 54:1473\u20131480","journal-title":"J Med Chem"},{"key":"3491_CR38","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1073\/pnas.1005114107","volume":"107","author":"N Carayol","year":"2010","unstructured":"Carayol N, Vakana E, Sassano A, Kaur S, Goussetis DJ, Glaser H, Druker BJ, Donato NJ, Altman JK, Barr S et al (2010) Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells. Proc Natl Acad Sci USA 107:12469\u201312474","journal-title":"Proc Natl Acad Sci USA"},{"key":"3491_CR39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villen J, Kubica N, Hoffman GR, Cantley LC, Gygi SP et al (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332:1322\u20131326","journal-title":"Science"},{"key":"3491_CR40","doi-asserted-by":"crossref","first-page":"1236566","DOI":"10.1126\/science.1236566","volume":"341","author":"SA Kang","year":"2013","unstructured":"Kang SA, Pacold ME, Cervantes CL, Lim D, Lou HJ, Ottina K, Gray NS, Turk BE, Yaffe MB, Sabatini DM (2013) mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 341:1236566","journal-title":"Science"},{"key":"3491_CR41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/onc.2014.17","volume":"34","author":"J Yang","year":"2015","unstructured":"Yang J, Kalogerou M, Samsel PA, Zhang Y, Griffiths DF, Gallacher J, Sampson JR, Shen MH (2015) Renal tumours in a Tsc2(+\/\u2212) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Oncogene 34:922\u2013931","journal-title":"Oncogene"},{"key":"3491_CR42","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bmcl.2013.01.019","volume":"23","author":"KG Pike","year":"2013","unstructured":"Pike KG, Malagu K, Hummersone MG, Menear KA, Duggan HM, Gomez S, Martin NM, Ruston L, Pass SL, Pass M (2013) Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014. Bioorg Med Chem Lett 23:1212\u20131216","journal-title":"Bioorg Med Chem Lett"},{"key":"3491_CR43","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/MCB.01035-14","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X, Regufe da Mota S, Liu R, Moore CE, Xie J, Lanucara F, Agarwala U, Pyr Dit Ruys S, Vertommen D, Rider MH et al (2014) Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Mol Cell Biol 34:4088\u20134103","journal-title":"Mol Cell Biol"},{"key":"3491_CR44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(91)80489-P","volume":"282","author":"NT Price","year":"1991","unstructured":"Price NT, Redpath NT, Severinov KV, Campbell DG, Russell JM, Proud CG (1991) Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes. FEBS Lett 282:253\u2013258","journal-title":"FEBS Lett"},{"key":"3491_CR45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20112107","volume":"444","author":"Y Huo","year":"2012","unstructured":"Huo Y, Iadevaia V, Yao Z, Kelly I, Cosulich S, Guichard S, Foster LJ, Proud CG (2012) Stable isotope-labelling analysis of the impact of inhibition of the mammalian target of rapamycin on protein synthesis. Biochem J 444:141\u2013151","journal-title":"Biochem J"},{"key":"3491_CR46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/35050135","volume":"408","author":"M Pende","year":"2000","unstructured":"Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Klumperman J, Thorens B, Thomas G (2000) Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408:994\u2013997","journal-title":"Nature"},{"key":"3491_CR47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/BJ20141066","volume":"467","author":"JE Beggs","year":"2015","unstructured":"Beggs JE, Tian S, Jones GG, Xie J, Iadevaia V, Jenei V, Thomas G, Proud CG (2015) The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E\/CYFIP1 binding. Biochem J 467:63\u201376","journal-title":"Biochem J"},{"key":"3491_CR48","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/onc.2014.146","volume":"34","author":"N Robichaud","year":"2015","unstructured":"Robichaud N, del Rincon SV, Huor B, Alain T, Petruccelli LA, Hearnden J, Goncalves C, Grotegut S, Spruck CH, Furic L et al (2015) Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene 34:2032\u20132042","journal-title":"Oncogene"},{"key":"3491_CR49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","volume":"21","author":"J Kim","year":"2019","unstructured":"Kim J, Guan KL (2019) mTOR as a central hub of nutrient signalling and cell growth. Nat Cell Biol 21:63\u201371","journal-title":"Nat Cell Biol"},{"key":"3491_CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/mcbr.2000.0217","volume":"3","author":"C Tschopp","year":"2000","unstructured":"Tschopp C, Knauf U, Brauchle M, Zurini M, Ramage P, Glueck D, New L, Han J, Gram H (2000) Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies. Mol Cell Biol Res Commun 3:205\u2013211","journal-title":"Mol Cell Biol Res Commun"},{"key":"3491_CR51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2018.10.070","volume":"162","author":"X Jin","year":"2018","unstructured":"Jin X, Merrett J, Tong S, Flower B, Xie J, Yu R, Tian S, Gao L, Zhao J, Wang X et al (2018) Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold. Eur J Med Chem 162:735\u2013751","journal-title":"Eur J Med Chem"},{"key":"3491_CR52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","volume":"408","author":"J Bain","year":"2007","unstructured":"Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297\u2013315","journal-title":"Biochem J"},{"key":"3491_CR53","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/acs.jmedchem.7b01795","volume":"61","author":"SH Reich","year":"2018","unstructured":"Reich SH, Sprengeler PA, Chiang GG, Appleman JR, Chen J, Clarine J, Eam B, Ernst JT, Han Q, Goel VK et al (2018) Structure-based design of pyridone-aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1\/2) inhibition. J Med Chem 61:3516\u20133540","journal-title":"J Med Chem"},{"key":"3491_CR54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412:179\u2013190","journal-title":"Biochem J"},{"key":"3491_CR55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","volume":"10","author":"D Ruggero","year":"2004","unstructured":"Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP (2004) The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10:484\u2013486","journal-title":"Nat Med"},{"key":"3491_CR56","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"HG Wendel","year":"2004","unstructured":"Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW (2004) Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428:332\u2013337","journal-title":"Nature"},{"key":"3491_CR57","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.celrep.2014.03.041","volume":"7","author":"A Maimon","year":"2014","unstructured":"Maimon A, Mogilevsky M, Shilo A, Golan-Gerstl R, Obiedat A, Ben-Hur V, Lebenthal-Loinger I, Stein I, Reich R, Beenstock J et al (2014) Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation. Cell Rep 7:501\u2013513","journal-title":"Cell Rep"},{"key":"3491_CR58","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1093\/nar\/gky921","volume":"46","author":"M Mogilevsky","year":"2018","unstructured":"Mogilevsky M, Shimshon O, Kumar S, Mogilevsky A, Keshet E, Yavin E, Heyd F, Karni R (2018) Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment. Nucleic Acids Res 46:11396\u201311404","journal-title":"Nucleic Acids Res"},{"key":"3491_CR59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"SH Um","year":"2004","unstructured":"Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J et al (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200\u2013205","journal-title":"Nature"},{"key":"3491_CR60","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, Peterson TR, Choi Y, Gray NS, Yaffe MB et al (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332:1317\u20131322","journal-title":"Science"},{"key":"3491_CR61","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.18632\/oncotarget.8767","volume":"7","author":"S Stelloo","year":"2016","unstructured":"Stelloo S, Sanders J, Nevedomskaya E, de Jong J, Peters D, van Leenders GJ, Jenster G, Bergman AM, Zwart W (2016) mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma. Oncotarget 7:32916\u201332924","journal-title":"Oncotarget"},{"key":"3491_CR62","first-page":"20","volume":"20","author":"AK Murugan","year":"2019","unstructured":"Murugan AK (2019) mTOR: Role in cancer, metastasis and drug resistance. Semin Cancer Biol 20:20","journal-title":"Semin Cancer Biol"},{"key":"3491_CR63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","volume":"104","author":"H Onda","year":"1999","unstructured":"Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ (1999) Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104:687\u2013695","journal-title":"J Clin Invest"},{"key":"3491_CR64","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1158\/1078-0432.CCR-12-0782","volume":"18","author":"MM Centenera","year":"2012","unstructured":"Centenera MM, Gillis JL, Hanson AR, Jindal S, Taylor RA, Risbridger GP, Sutherland PD, Scher HI, Raj GV, Knudsen KE et al (2012) Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors. Clin Cancer Res 18:3562\u20133570","journal-title":"Clin Cancer Res"},{"key":"3491_CR65","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","volume":"8","author":"CF Bentzinger","year":"2008","unstructured":"Bentzinger CF, Romanino K, Cloetta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M et al (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8:411\u2013424","journal-title":"Cell Metab"},{"key":"3491_CR66","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/stem.1931","volume":"33","author":"SK Martin","year":"2015","unstructured":"Martin SK, Fitter S, Dutta AK, Matthews MP, Walkley CR, Hall MN, Ruegg MA, Gronthos S, Zannettino AC (2015) Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells 33:1359\u20131365","journal-title":"Stem Cells"},{"key":"3491_CR67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/MCB.00668-16","volume":"37","author":"S Fitter","year":"2017","unstructured":"Fitter S, Matthews MP, Martin SK, Xie J, Ooi SS, Walkley CR, Codrington JD, Ruegg MA, Hall MN, Proud CG et al (2017) mTORC1 plays an important role in skeletal development by controlling preosteoblast differentiation. Mol Cell Biol 37:20","journal-title":"Mol Cell Biol"},{"key":"3491_CR68","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/mt.2008.6","volume":"16","author":"K Weber","year":"2008","unstructured":"Weber K, Bartsch U, Stocking C, Fehse B (2008) A multicolor panel of novel lentiviral \"gene ontology\" (LeGO) vectors for functional gene analysis. Mol Ther 16:698\u2013706","journal-title":"Mol Ther"},{"key":"3491_CR69","doi-asserted-by":"crossref","first-page":"46121","DOI":"10.18632\/oncotarget.17555","volume":"8","author":"S Tian","year":"2017","unstructured":"Tian S, Wang X, Proud CG (2017) Oncogenic MNK signalling regulates the metastasis suppressor NDRG1. Oncotarget 8:46121\u201346135","journal-title":"Oncotarget"},{"key":"3491_CR70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"3491_CR71","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.cellsig.2011.06.025","volume":"23","author":"J Xie","year":"2011","unstructured":"Xie J, Ponuwei GA, Moore CE, Willars GB, Tee AR, Herbert TP (2011) cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Cell Signal 23:1927\u20131935","journal-title":"Cell Signal"},{"key":"3491_CR72","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/MCB.00012-15","volume":"35","author":"J Xie","year":"2015","unstructured":"Xie J, Mikolajek H, Pigott CR, Hooper KJ, Mellows T, Moore CE, Mohammed H, Werner JM, Thomas GJ, Proud CG (2015) Molecular mechanism for the control of eukaryotic elongation factor 2 kinase by pH: role in cancer cell survival. Mol Cell Biol 35:1805\u20131824","journal-title":"Mol Cell Biol"},{"key":"3491_CR73","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jmb.2009.04.020","volume":"389","author":"CE Moore","year":"2009","unstructured":"Moore CE, Xie J, Gomez E, Herbert TP (2009) Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells. J Mol Biol 389:480\u2013494","journal-title":"J Mol Biol"},{"key":"3491_CR74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2867-10-13","volume":"10","author":"TG Natarajan","year":"2010","unstructured":"Natarajan TG, Kallakury BV, Sheehan CE, Bartlett MB, Ganesan N, Preet A, Ross JS, FitzGerald KT (2010) Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon. Cancer Cell Int 10:13","journal-title":"Cancer Cell Int"},{"key":"3491_CR75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/JME-13-0200","volume":"53","author":"J Xie","year":"2014","unstructured":"Xie J, El Sayed NM, Qi C, Zhao X, Moore CE, Herbert TP (2014) Exendin-4 stimulates islet cell replication via the IGF1 receptor activation of mTORC1\/S6K1. J Mol Endocrinol 53:105\u2013115","journal-title":"J Mol Endocrinol"},{"key":"3491_CR76","doi-asserted-by":"crossref","first-page":"56650","DOI":"10.18632\/oncotarget.10992","volume":"7","author":"K Shen","year":"2016","unstructured":"Shen K, Xi Z, Xie J, Wang H, Xie C, Lee CS, Fahey P, Dong Q, Xu H (2016) Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1. Oncotarget 7:56650\u201356663","journal-title":"Oncotarget"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03491-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-020-03491-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03491-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:53:24Z","timestamp":1615596804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-020-03491-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3491"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03491-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}